IL17A and psoriasis: Especially TNF-α, IL-17A and IL-12/IL-23 are believed to play a key role in the pathogenesis of psoriasis, which is confirmed by the successful use of antibodies directed against these cytokines in the treatment of psoriasis[1-3].